Lataa...
Molecular subtyping bladder cancer: Is it ready for clinical practice?
Bladder cancer, one of the more common cancers, is a heterogeneous disease, both morphologically and clinically. Although histological classification and extent of the disease (staging) guide treatment options, the heterogeneity in responses to therapy highlights the need for better stratification o...
Tallennettuna:
| Julkaisussa: | Turk J Med Sci |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Scientific and Technological Research Council of Turkey
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672344/ https://ncbi.nlm.nih.gov/pubmed/32336078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-2004-200 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|